BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12134461)

  • 1. Prevention for the older woman. A practical guide to managing cardiovascular disease.
    Messinger-Rapport BJ; Thacker HL
    Geriatrics; 2002 Jul; 57(7):22-6, 29-30. PubMed ID: 12134461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary and secondary prevention of cardiovascular disease in the elderly.
    GarcĂ­a-Palmieri MR
    Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of cardiovascular complications after a stroke or TIA: hypotensive and hypocholesterolemic therapy].
    Dippel DW; van der Worp HB
    Ned Tijdschr Geneeskd; 2004 Apr; 148(17):820-4. PubMed ID: 15141647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing cardiovascular disease in women.
    Hayes SN
    Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin use in the prevention of cardiovascular events.
    Crutcher JM; Mallonee S; Daniels C
    J Okla State Med Assoc; 2007 Oct; 100(10):383-7. PubMed ID: 18085095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and prevention of cardiovascular disease in women.
    Price JA
    Nurs Clin North Am; 2004 Dec; 39(4):873-84, xi. PubMed ID: 15561167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of the heart: building science to improve women's cardiovascular health.
    Rosenfeld AG
    Am J Crit Care; 2006 Nov; 15(6):556-66; quiz 567. PubMed ID: 17053263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on aspirin in the primary prevention of cardiovascular disease.
    Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
    Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study).
    Mizuno K; Nakaya N; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
    Circulation; 2008 Jan; 117(4):494-502. PubMed ID: 18172039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Women and cardiovascular diseases].
    Sannito N; Lovreglio V
    Minerva Cardioangiol; 2002 Apr; 50(2):107-16. PubMed ID: 12032464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
    Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
    Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Women and cardiovascular disease].
    Sluman MA; Verhaar MC; van der Wall EE; Westerveld HE
    Ned Tijdschr Geneeskd; 2006 Sep; 150(37):2018-22. PubMed ID: 17058457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.